DI PRIMA, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 136
EU - Europa 50
AS - Asia 24
AF - Africa 1
SA - Sud America 1
Totale 212
Nazione #
US - Stati Uniti d'America 135
IT - Italia 23
SG - Singapore 12
BG - Bulgaria 8
IN - India 8
SE - Svezia 5
DE - Germania 3
BE - Belgio 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
CN - Cina 1
DK - Danimarca 1
IS - Islanda 1
JP - Giappone 1
LU - Lussemburgo 1
NL - Olanda 1
PE - Perù 1
PL - Polonia 1
TG - Togo 1
Totale 212
Città #
Chandler 22
Ashburn 17
Fairfield 16
Sofia 8
Singapore 7
Wilmington 7
Houston 6
Seattle 6
Cambridge 5
Cagliari 4
New York 4
Princeton 4
Rome 4
Woodbridge 4
Millbury 3
Bremen 2
Brussels 2
Palestrina 2
San Paolo di Civitate 2
Accadia 1
Amsterdam 1
Ann Arbor 1
Bologna 1
Copenhagen 1
Dhaka 1
Frankfurt am Main 1
Hangzhou 1
Keflavik 1
Laurel 1
Lawrence 1
Lima 1
Lomé 1
Los Angeles 1
Luxembourg 1
Milan 1
Norwalk 1
San Diego 1
Tirana 1
Tokyo 1
Toronto 1
Trento 1
Washington 1
Yerevan 1
Zurich 1
Totale 150
Nome #
Prognostic significance of PET/CT in patients with chronic lymphocytic leukemia (CLL) treated with frontline chemoimmunotherapy 66
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors 55
null 28
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia. is it time to introduce it in the clinical practice? 18
null 17
Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice 16
Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience 10
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab 9
Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up 6
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients 4
The advantages and risks of ruxolitinib for the treatment of polycythemia vera 4
Hemoglobin Changes during Long-Lasting Frontline Treatment with Tyrosine-Kinase Inhibitors in Patients with Chronic Myeloid Leukemia 3
Totale 236
Categoria #
all - tutte 1.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.011


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 5 22 6 2 2 0 0 8 4
2021/202249 5 0 0 2 12 3 2 2 6 1 9 7
2022/202364 11 8 3 9 10 4 1 8 7 0 2 1
2023/202473 7 7 4 5 7 14 0 3 0 13 3 10
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 236